Galapagos NV (GLPGF) SEC Filings — 2024

Filings

• Galapagos NV Files 6-K, Incorporates Press Release — 6-K · Dec 9, 2024
• Galapagos NV SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Galapagos NV Files Form 6-K with Press Release — 6-K · Nov 6, 2024
• Galapagos NV Files 6-K, Incorporates October 30 Press Release — 6-K · Oct 31, 2024
• EcoR1 Capital Amends Galapagos NV Filing — SC 13D/A · Oct 8, 2024
• Galapagos NV Files 6-K, Incorporates Press Release — 6-K · Oct 7, 2024
• Galapagos NV Files 6-K, Incorporates Press Release — 6-K · Sep 30, 2024
• Galapagos NV Files Form 6-K with SEC — 6-K · Sep 16, 2024
• Galapagos NV Files Form 6-K with Press Release — 6-K · Sep 3, 2024
• Galapagos NV Files 6-K, Incorporates Press Release — 6-K · Aug 23, 2024
• EcoR1 Capital Discloses Stake in Galapagos NV — SC 13D · Aug 23, 2024
• Galapagos NV Files 6-K, Incorporates Press Release — 6-K · Aug 21, 2024
• Galapagos NV Reports H1 2024 Results — 6-K · Aug 2, 2024
• Galapagos & Moderna Partner on mRNA Cystic Fibrosis Drugs — 6-K · Jun 17, 2024
• Galapagos NV Appoints Dr. Paul Stoffels as New CEO — 6-K · May 30, 2024
• Galapagos to Acquire Verseau Therapeutics for $150M — 6-K · May 16, 2024
• Galapagos NV Files 6-K, Incorporates Press Release — 6-K · May 3, 2024
• Gilead Sciences Amends Galapagos NV 13D Filing — SC 13D/A · May 2, 2024
• Galapagos NV Shareholders' Meetings Held April 30 — 6-K · May 1, 2024
• Galapagos NV Files Form 6-K with SEC — 6-K · May 1, 2024
• Galapagos NV Partners with UCSF for Drug Discovery — 6-K · Apr 8, 2024
• Galapagos NV Files March 2024 6-K Report — 6-K · Mar 29, 2024
• Galapagos NV Files 6-K, Incorporates Press Release — 6-K · Mar 29, 2024
• Galapagos NV Files 20-F Annual Report for Fiscal Year 2023 — 20-F · Mar 28, 2024
• Galapagos Files 6-K, Incorporates Press Release into S-8s — 6-K · Feb 23, 2024
• Galapagos NV Files 6-K, Incorporates Feb 15 Press Release — 6-K · Feb 16, 2024
• Galapagos NV SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• FMR LLC & Abigail Johnson Hold 7.732% Stake in Galapagos NV — SC 13G/A · Feb 9, 2024
• Galapagos Completes Jyseleca® Business Transfer to Alfasigma — 6-K · Feb 6, 2024
• Galapagos Partners with Thermo Fisher for US CAR-T Manufacturing — 6-K · Jan 5, 2024
• Galapagos to Divest Jyseleca® Business to Alfasigma by Q1 2024 — 6-K · Jan 4, 2024